(Q71256022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

S Antila

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

J Eha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

M Heinpalu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

L Lehtonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

I Loogna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

A Mesikepp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

U Planken

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

E P Sandell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

451-458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00195930

17 October 2019

exact match

0 references

cites work

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

1 reference

12 December 2020

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

1 reference

12 December 2020

Haemodynamic dose-efficacy of levosimendan in healthy volunteers.

1 reference

12 December 2020

The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Safety of levosimendan and other calcium sensitizers

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers

1 reference

12 December 2020

ACE inhibitors after myocardial infarction

1 reference

12 December 2020

Mechanisms of action of calcium-sensitizing drugs

1 reference

12 December 2020

Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.

1 reference

12 December 2020

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

1 reference

12 December 2020

Pharmacokinetics of levosimendan in healthy volunteers and patients with congestive heart failure

1 reference

12 December 2020

Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.

1 reference

12 December 2020

Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00195930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8706769%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference